MedPath

ong term outcome of renal nerve denervation for resistant hypertension in Thai patients

Completed
Conditions
All patients with resistant hypertension whom underwent renal nerve denervation
Resistant hypertension, Renal nerve denervation, blood pressure reduction, sleep apnea
Registration Number
TCTR20210323006
Lead Sponsor
/A
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
18
Inclusion Criteria

1. Patients older than 18 years with hypertension (systolic BP) greater than 160 mm Hg. After taking more than 3 antihypertensive drugs, one of which was a diuretic. And are patients who plan to be treated for hypertension with renal denervation (who are already on treatment).

Exclusion Criteria

1. People with abnormal renal function (eGFR <45ml / min).
2. People with valve stenosis.
3.People with a history of ischemic heart attack, unstable angina, or stroke within 6 months.
4.Patients receiving pacemakers or Automatic Implantable Cardioverter Defibrillators (AICD).
5. Patients with renal vascular disorders For example, with stenosis or had a stent inserted before or have more than one renal artery on each side.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of renal denervation procedure 3, 6, 12 months, then annually up to 6 years percentage of Efficacy
Secondary Outcome Measures
NameTimeMethod
/A N/A N/A
© Copyright 2025. All Rights Reserved by MedPath